Gossamer Bio Faces Lawsuit Over Study Misconduct

Gossamer Bio, Inc. is facing a class action lawsuit for allegedly fibbing about their Phase 3 PROSERA study, especially on how they handled placebo responses at certain sites. If you bought Gossamer's securities between June 16, 2025, and February 20, 2026, you might want to join the lawsuit by June 1, 2026, to potentially get back some lost cash. What does it mean for you? If you've got cash tied up in Gossamer and feel the burn from their alleged truth-bending, this lawsuit might be your ticket to some financial justice. Plus, it's a reminder to keep an eye on where you park your hard-earned money.